Pathways to healing: Plants with therapeutic potential for neurodegenerative diseases

[1]  M. Kazakova,et al.  Neuroinflammation and Autophagy in Parkinson’s Disease—Novel Perspectives , 2022, International journal of molecular sciences.

[2]  Timothy A. Miller,et al.  Trial of Antisense Oligonucleotide Tofersen for SOD1 ALS. , 2022, The New England journal of medicine.

[3]  S. E. Tyler,et al.  Therapeutic roles of plants for 15 hypothesised causal bases of Alzheimer’s disease , 2022, Natural Products and Bioprospecting.

[4]  K. Landry,et al.  Oral Dysbiosis and Neurodegenerative Diseases: Correlations and Potential Causations , 2022, Microorganisms.

[5]  Jikai Liu Antiaging agents: safe interventions to slow aging and healthy life span extension , 2022, Natural products and bioprospecting.

[6]  G. Lopez,et al.  Neuropathological Features of Gaucher Disease and Gaucher Disease with Parkinsonism , 2022, International journal of molecular sciences.

[7]  S. Buduru,et al.  Oral Microbiome: Getting to Know and Befriend Neighbors, a Biological Approach , 2022, Biomedicines.

[8]  Victor Tapias,et al.  Blueberry juice augments exercise-induced neuroprotection in a Parkinson’s disease model through modulation of GDNF levels , 2022, IBRO neuroscience reports.

[9]  R. Fischer,et al.  Phenotypic manifestation of α-synuclein strains derived from Parkinson’s disease and multiple system atrophy in human dopaminergic neurons , 2021, Nature Communications.

[10]  A. Strasser,et al.  Molecular mechanisms of cell death in neurological diseases , 2021, Cell Death & Differentiation.

[11]  H. Rahimi,et al.  Brain-derived neurotrophic factor (BDNF) variation to aerobic exercise and aloe vera intake in women with type 2 diabetes , 2021 .

[12]  R. Itzhaki Overwhelming Evidence for a Major Role for Herpes Simplex Virus Type 1 (HSV1) in Alzheimer’s Disease (AD); Underwhelming Evidence against , 2021, Vaccines.

[13]  Vincent Marcucci,et al.  Biomarkers and Their Implications in Alzheimer’s Disease: A Literature Review , 2021 .

[14]  P. Carlier,et al.  Promising tacrine/huperzine A‐based dimeric acetylcholinesterase inhibitors for neurodegenerative disorders: From relieving symptoms to modifying diseases through multitarget , 2021, Journal of neurochemistry.

[15]  Sungtae Yoon,et al.  Mitochondrial Dynamics: A Key Role in Neurodegeneration and a Potential Target for Neurodegenerative Disease , 2021, Frontiers in Neuroscience.

[16]  Jinfang Zhu,et al.  Recent advances in understanding the Th1/Th2 effector choice , 2021, Faculty reviews.

[17]  K. Luk,et al.  α-Synuclein antisense oligonucleotides as a disease-modifying therapy for Parkinson’s disease , 2021, JCI insight.

[18]  N. Jana,et al.  Withaferin A Induces Heat Shock Response and Ameliorates Disease Progression in a Mouse Model of Huntington’s Disease , 2021, Molecular Neurobiology.

[19]  C. Balducci,et al.  Accelerating Alzheimer’s disease drug discovery and development: what’s the way forward? , 2021, Expert opinion on drug discovery.

[20]  A. Laguna,et al.  New Avenues for Parkinson’s Disease Therapeutics: Disease-Modifying Strategies Based on the Gut Microbiota , 2021, Biomolecules.

[21]  R. Bauer,et al.  Natural products in drug discovery: advances and opportunities , 2021, Nature Reviews Drug Discovery.

[22]  K. Kurz,et al.  The Immunopathogenesis of Alzheimer’s Disease Is Related to the Composition of Gut Microbiota , 2021, Nutrients.

[23]  Jin-Ming Yang,et al.  DNA Repair Pathways in Cancer Therapy and Resistance , 2021, Frontiers in Pharmacology.

[24]  T. Vos,et al.  Estimating the global mortality from Alzheimer’s disease and other dementias: A new method and results from the Global Burden of Disease study 2019 , 2020, Alzheimer's & Dementia.

[25]  S. A. Naqvi,et al.  Calotropis procera (root) escalates functions rehabilitation and attenuates oxidative stress in a mouse model of peripheral nerve injury. , 2020, Pakistan journal of pharmaceutical sciences.

[26]  A. Tsatsakis,et al.  Curcumin Formulations and Trials: What’s New in Neurological Diseases , 2020, Molecules.

[27]  R. Pettigrew,et al.  Achieving healthy human longevity: A global grand challenge , 2020, Science Translational Medicine.

[28]  C. Blizzard,et al.  Mislocalisation of TDP‐43 to the cytoplasm causes cortical hyperexcitability and reduced excitatory neurotransmission in the motor cortex , 2020, Journal of neurochemistry.

[29]  Chongming Wu,et al.  The Gut Microbiota-Produced Indole-3-Propionic Acid Confers the Antihyperlipidemic Effect of Mulberry-Derived 1-Deoxynojirimycin , 2020, mSystems.

[30]  R. Ghemrawi,et al.  Endoplasmic Reticulum Stress and Unfolded Protein Response in Neurodegenerative Diseases , 2020, International journal of molecular sciences.

[31]  R. León,et al.  When It Comes to an End: Oxidative Stress Crosstalk with Protein Aggregation and Neuroinflammation Induce Neurodegeneration , 2020, Antioxidants.

[32]  Marwa I Ezzat,et al.  Neuroprotective effects of Pulicaria undulata essential oil in rotenone model of parkinson's disease in rats: Insights into its anti-inflammatory and anti-oxidant effects , 2020 .

[33]  M. Maes,et al.  Preventive treatments to slow substantia nigra damage and Parkinson's disease progression: a critical perspective review. , 2020, Pharmacological research.

[34]  Claire K. Ankuda,et al.  Family Caregiving at the End of Life and Hospice Use: A National Study of Medicare Beneficiaries , 2020, Journal of the American Geriatrics Society.

[35]  P. van Damme,et al.  Amyotrophic lateral sclerosis: a clinical review , 2020, European journal of neurology.

[36]  T. Finkel,et al.  Mitochondria as intracellular signaling platforms in health and disease , 2020, The Journal of cell biology.

[37]  David J Newman,et al.  Natural Products as Sources of New Drugs over the Nearly Four Decades from 01/1981 to 09/2019. , 2020, Journal of natural products.

[38]  M. Heneka,et al.  Do infections have a role in the pathogenesis of Alzheimer disease? , 2020, Nature Reviews Neurology.

[39]  I. Ferrer,et al.  The Quest for Cellular Prion Protein Functions in the Aged and Neurodegenerating Brain , 2020, Cells.

[40]  Enrico Giampieri,et al.  Mediterranean diet intervention alters the gut microbiome in older people reducing frailty and improving health status: the NU-AGE 1-year dietary intervention across five European countries , 2020, Gut.

[41]  N. Brandon,et al.  The clinical trial landscape in amyotrophic lateral sclerosis—Past, present, and future , 2020, Medicinal research reviews.

[42]  Shaoyan Zheng Protective effect of Polygonatum sibiricum Polysaccharide on D-galactose-induced aging rats model , 2020, Scientific Reports.

[43]  Martina Kunkl,et al.  T Helper Cells: The Modulators of Inflammation in Multiple Sclerosis , 2020, Cells.

[44]  E. Bertini,et al.  The NRF2 Signaling Network Defines Clinical Biomarkers and Therapeutic Opportunity in Friedreich’s Ataxia , 2020, International journal of molecular sciences.

[45]  Vijay Kumar,et al.  Therapeutic Advances for Huntington’s Disease , 2020, Brain sciences.

[46]  S. Ojha,et al.  Therapeutic Potential of Baicalein in Parkinson’s Disease: Focus on Inhibition of α-Synuclein Oligomerization and Aggregation , 2019, Synucleins - Biochemistry and Role in Diseases.

[47]  Z. Yue,et al.  Autophagy and Parkinson's Disease. , 2020, Advances in experimental medicine and biology.

[48]  C. Helmstaedter,et al.  Anticonvulsant Drugs and Cognition , 2020 .

[49]  C. Alméciga-Díaz,et al.  Advances in the Development of Pharmacological Chaperones for the Mucopolysaccharidoses , 2019, International journal of molecular sciences.

[50]  V. Krajka-Kuźniak,et al.  Neuroprotective Effects of Pomegranate Juice against Parkinson’s Disease and Presence of Ellagitannins-Derived Metabolite—Urolithin A—In the Brain , 2019, International journal of molecular sciences.

[51]  A. E. Speck,et al.  Role of Adenosine A2A Receptors in the Central Fatigue of Neurodegenerative Diseases , 2019 .

[52]  Narttaya Chaiwiang,et al.  Microbial dysbiosis and microbiota-gut-retina axis: The lesson from brain neurodegenerative diseases to primary open-angle glaucoma pathogenesis of autoimmunity. , 2019, Acta microbiologica et immunologica Hungarica.

[53]  Y. Jammes,et al.  Understanding neuromuscular disorders in chronic fatigue syndrome , 2019, F1000Research.

[54]  M. Artola,et al.  Glycosphingolipids and lysosomal storage disorders as illustrated by gaucher disease. , 2019, Current opinion in chemical biology.

[55]  Xudong Huang,et al.  Contributing Factors of Neurodegeneration in Alzheimer’s Disease , 2019 .

[56]  Kumju Youn,et al.  Discovery of Nobiletin from Citrus Peel as a Potent Inhibitor of β-Amyloid Peptide Toxicity , 2019, Nutrients.

[57]  G. Grynkiewicz,et al.  New Perspectives for Fisetin , 2019, Front. Chem..

[58]  ALSUntangled No. 50: Antifungal Therapy , 2019, Amyotrophic lateral sclerosis & frontotemporal degeneration.

[59]  J. Trojanowski,et al.  α-Synuclein pathology in Parkinson’s disease and related α-synucleinopathies , 2019, Neuroscience Letters.

[60]  R. Maccioni,et al.  Neuroinflammation as a Common Feature of Neurodegenerative Disorders , 2019, Front. Pharmacol..

[61]  A. Bräuer,et al.  Current Challenges in Understanding the Cellular and Molecular Mechanisms in Niemann–Pick Disease Type C1 , 2019, International journal of molecular sciences.

[62]  M. Larhammar,et al.  Cell Death and Neurodegeneration. , 2019, Cold Spring Harbor perspectives in biology.

[63]  J. Tepe,et al.  Proteasome Activation to Combat Proteotoxicity , 2019, Molecules.

[64]  Hari Prasad Devkota,et al.  Synergistic interactions of phytochemicals with antimicrobial agents: Potential strategy to counteract drug resistance. , 2019, Chemico-biological interactions.

[65]  D. Rhoads,et al.  Clinical Laboratory Tests Used To Aid in Diagnosis of Human Prion Disease , 2019, Journal of Clinical Microbiology.

[66]  R. Truant,et al.  DNA Damage Repair in Huntington’s Disease and Other Neurodegenerative Diseases , 2019, Neurotherapeutics.

[67]  T. Pandita,et al.  Prion disease is accelerated in mice lacking stress-induced heat shock protein 70 (HSP70) , 2019, The Journal of Biological Chemistry.

[68]  Z. Illés,et al.  Immunological Aspects of Approved MS Therapeutics , 2019, Front. Immunol..

[69]  Anirudh Gupta,et al.  Charcot-Marie-Tooth: From Molecules to Therapy , 2019, International journal of molecular sciences.

[70]  K. Sandhoff,et al.  Lysosomal Glycosphingolipid Storage Diseases. , 2019, Annual review of biochemistry.

[71]  N. Cech,et al.  Synergy and antagonism in natural product extracts: when 1 + 1 does not equal 2. , 2019, Natural product reports.

[72]  J. Duarte,et al.  Mitochondria and the Brain: Bioenergetics and Beyond , 2019, Neurotoxicity Research.

[73]  R. D. de Moura,et al.  Antihypertensive effects of the Vitis vinifera grape skin (ACH09) extract consumption elicited by functional improvement of P1 (A1) and P2 (P2X1) purinergic receptors in diabetic and hypertensive rats , 2019, PharmaNutrition.

[74]  M. Tremblay,et al.  Inflammatory mechanisms in neurodegeneration , 2019, Journal of neurochemistry.

[75]  Yunqi Lv,et al.  Neuroprotection of Resveratrol Against Focal Cerebral Ischemia/Reperfusion Injury in Mice Through a Mechanism Targeting Gut-Brain Axis , 2019, Cellular and Molecular Neurobiology.

[76]  P. Lajoie,et al.  Endoplasmic Reticulum Stress Coping Mechanisms and Lifespan Regulation in Health and Diseases , 2019, Front. Cell Dev. Biol..

[77]  Ming Ye,et al.  DL-3-n-butylphthalide therapy for Parkinson's disease: A randomized controlled trial. , 2019, Experimental and therapeutic medicine.

[78]  D. Eatman,et al.  Effects of Resveratrol on Inflammatory Biomarkers in Glaucomatous Human Trabecular Meshwork Cells , 2019, Nutrients.

[79]  Beth Stevens,et al.  Immune Signaling in Neurodegeneration. , 2019, Immunity.

[80]  Alexandra B. Nelson,et al.  Circuit Mechanisms of Parkinson’s Disease , 2019, Neuron.

[81]  V. Parisi,et al.  Neuroinflammation as a target for glaucoma therapy , 2019, Neural regeneration research.

[82]  S. Snyder,et al.  Redox Mechanisms in Neurodegeneration: From Disease Outcomes to Therapeutic Opportunities. , 2019, Antioxidants & redox signaling.

[83]  R. Gold,et al.  Progressive multiple sclerosis: latest therapeutic developments and future directions , 2019, Therapeutic advances in neurological disorders.

[84]  Z. Hua,et al.  Apoptosis and apoptotic body: disease message and therapeutic target potentials , 2018, Bioscience reports.

[85]  Robert W. Taylor,et al.  Dissecting the neuronal vulnerability underpinning Alpers’ syndrome: a clinical and neuropathological study , 2018, Brain pathology.

[86]  C. Hudon,et al.  Polyphenols From Grape and Blueberry Improve Episodic Memory in Healthy Elderly with Lower Level of Memory Performance: A Bicentric Double-Blind, Randomized, Placebo-Controlled Clinical Study. , 2018, The journals of gerontology. Series A, Biological sciences and medical sciences.

[87]  J. Mouslim,et al.  Medicinal and Aromatic Plants Used in Traditional Treatment of the Oral Pathology: The Ethnobotanical Survey in the Economic Capital Casablanca, Morocco (North Africa) , 2018, Natural Products and Bioprospecting.

[88]  Yan Liu,et al.  Beneficial effect of compound essential oil inhalation on central fatigue , 2018, BMC Complementary and Alternative Medicine.

[89]  E. Acquas,et al.  Standardized phytotherapic extracts rescue anomalous locomotion and electrophysiological responses of TDP-43 Drosophila melanogaster model of ALS , 2018, Scientific Reports.

[90]  S. Rahman,et al.  POLG-related disorders and their neurological manifestations , 2018, Nature Reviews Neurology.

[91]  G. Breen,et al.  Retrotransposons in the development and progression of amyotrophic lateral sclerosis , 2018, Journal of Neurology, Neurosurgery, and Psychiatry.

[92]  Hui-yun Chang,et al.  Neuronal Cell Death Mechanisms in Major Neurodegenerative Diseases , 2018, International journal of molecular sciences.

[93]  B. Davidson,et al.  Lysosomal storage diseases , 2018, Nature Reviews Disease Primers.

[94]  C. Tilikete,et al.  Adult Niemann-Pick disease type C in France: clinical phenotypes and long-term miglustat treatment effect , 2018, Orphanet Journal of Rare Diseases.

[95]  M. Hayden,et al.  Therapeutic approaches to Huntington disease: from the bench to the clinic , 2018, Nature Reviews Drug Discovery.

[96]  Xiaohui Xu,et al.  Protective Effects of 2-Dodecyl-6-Methoxycyclohexa-2,5 -Diene-1,4-Dione Isolated from Averrhoa Carambola L. (Oxalidaceae) Roots on Neuron Apoptosis and Memory Deficits in Alzheimer's Disease , 2018, Cellular Physiology and Biochemistry.

[97]  S. Hickman,et al.  Microglia in neurodegeneration , 2018, Nature Neuroscience.

[98]  Yifan Feng,et al.  Resveratrol ameliorates disorders of mitochondrial biogenesis and dynamics in a rat chronic ocular hypertension model , 2018, Life sciences.

[99]  Xinghuai Sun,et al.  Asiatic Acid Prevents Retinal Ganglion Cell Apoptosis in a Rat Model of Glaucoma , 2018, Front. Neurosci..

[100]  M. Pallàs,et al.  Resveratrol Induces Brain Resilience Against Alzheimer Neurodegeneration Through Proteostasis Enhancement , 2018, Molecular Neurobiology.

[101]  K. Ochiai,et al.  Gingival Periodontal Disease (PD) Level-Butyric Acid Affects the Systemic Blood and Brain Organ: Insights Into the Systemic Inflammation of Periodontal Disease , 2018, Front. Immunol..

[102]  Luis Carrasco,et al.  Infection of Fungi and Bacteria in Brain Tissue From Elderly Persons and Patients With Alzheimer’s Disease , 2018, Front. Aging Neurosci..

[103]  H. Jiang,et al.  Fisetin Exerts Antioxidant and Neuroprotective Effects in Multiple Mutant hSOD1 Models of Amyotrophic Lateral Sclerosis by Activating ERK , 2018, Neuroscience.

[104]  A. Sun Lysosomal storage disease overview. , 2018, Annals of translational medicine.

[105]  Soo-Jin Jeong,et al.  The Anti-neuroinflammatory Activity of Tectorigenin Pretreatment via Downregulated NF-κB and ERK/JNK Pathways in BV-2 Microglial and Microglia Inactivation in Mice With Lipopolysaccharide , 2018, Front. Pharmacol..

[106]  M. Cavinato,et al.  Targeting Protein Quality Control Mechanisms by Natural Products to Promote Healthy Ageing , 2018, Molecules.

[107]  V. Baekelandt,et al.  Linking Neuroinflammation and Neurodegeneration in Parkinson's Disease , 2018, Journal of immunology research.

[108]  G. Courtois,et al.  The Many Roles of Ubiquitin in NF-κB Signaling , 2018, Biomedicines.

[109]  M. Maes,et al.  The Endoplasmic Reticulum Stress Response in Neuroprogressive Diseases: Emerging Pathophysiological Role and Translational Implications , 2018, Molecular Neurobiology.

[110]  P. Pal,et al.  Tremor syndromes: A review , 2018, Neurology India.

[111]  R. Bedlack ALSUntangled 44: curcumin , 2018, Amyotrophic lateral sclerosis & frontotemporal degeneration.

[112]  R. Harding,et al.  Proteostasis in Huntington's disease: disease mechanisms and therapeutic opportunities , 2018, Acta Pharmacologica Sinica.

[113]  P. Andrade,et al.  Tuning protein folding in lysosomal storage diseases: the chemistry behind pharmacological chaperones , 2018, Chemical science.

[114]  D. Reich,et al.  Multiple Sclerosis , 2018, The New England journal of medicine.

[115]  S. Rai,et al.  Mucuna pruriens Protects against MPTP Intoxicated Neuroinflammation in Parkinson’s Disease through NF-κB/pAKT Signaling Pathways , 2017, Front. Aging Neurosci..

[116]  T. Friede,et al.  A standardised frankincense extract reduces disease activity in relapsing-remitting multiple sclerosis (the SABA phase IIa trial) , 2017, Journal of Neurology, Neurosurgery, and Psychiatry.

[117]  S. Sarkar,et al.  Dysregulation of autophagy as a common mechanism in lysosomal storage diseases , 2017, Essays in biochemistry.

[118]  Natalie C. Ward,et al.  The cardiovascular health benefits of apples: Whole fruit vs. isolated compounds , 2017 .

[119]  C. Chin,et al.  Epigenetic Regulatory Mechanisms Induced by Resveratrol , 2017, Nutrients.

[120]  Anders Larsson,et al.  Global, regional, and national burden of neurological disorders during 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015 , 2017, The Lancet Neurology.

[121]  Yanhua Lu,et al.  Antibacterial and antibiofilm activities of eugenol from essential oil of Syzygium aromaticum (L.) Merr. & L. M. Perry (clove) leaf against periodontal pathogen Porphyromonas gingivalis. , 2017, Microbial pathogenesis.

[122]  K. Acharya,et al.  A Comprehensive Review on Food and Medicinal Prospects of Astraeus hygrometricus , 2017 .

[123]  S. Packman,et al.  Outcomes after 18 months of eliglustat therapy in treatment‐naïve adults with Gaucher disease type 1: The phase 3 ENGAGE trial , 2017, American journal of hematology.

[124]  S. Hassan,et al.  A Therapeutic Connection between Dietary Phytochemicals and ATP Synthase , 2017, Current medicinal chemistry.

[125]  A. Ganji,et al.  Artemisinin therapeutic efficacy in the experimental model of multiple sclerosis , 2017, Immunopharmacology and immunotoxicology.

[126]  J. R. Liddell,et al.  Are Astrocytes the Predominant Cell Type for Activation of Nrf2 in Aging and Neurodegeneration? , 2017, Antioxidants.

[127]  Ke-Li Chen,et al.  A comparative study of anti-aging properties and mechanism: resveratrol and caloric restriction , 2017, Oncotarget.

[128]  R. Gold,et al.  Efficacy and Tolerability of Delayed-release Dimethyl Fumarate in Black, Hispanic, and Asian Patients with Relapsing-Remitting Multiple Sclerosis: Post Hoc Integrated Analysis of DEFINE and CONFIRM , 2017, Neurology and Therapy.

[129]  R. Gold,et al.  Efficacy and Safety of Delayed-release Dimethyl Fumarate for Relapsing-remitting Multiple Sclerosis in Prior Interferon Users: An Integrated Analysis of DEFINE and CONFIRM. , 2017, Clinical therapeutics.

[130]  M. Contin,et al.  Mucuna pruriens in Parkinson disease , 2017, Neurology.

[131]  J. Flickinger,et al.  T-bet-dependent NKp46+ innate lymphoid cells regulate the onset of TH17-induced neuroinflammation , 2017, Nature Immunology.

[132]  J. Salazar,et al.  The Role of Microglia in Retinal Neurodegeneration: Alzheimer's Disease, Parkinson, and Glaucoma , 2017, Front. Aging Neurosci..

[133]  W. Setzer,et al.  In Vitro Testing of Crude Natural Plant Extracts from Costa Rica for Their Ability to Boost Innate Immune Cells against Staphylococcus aureus , 2017, Biomedicines.

[134]  C. Dionisi-Vici,et al.  The treatment of juvenile/adult GM1-gangliosidosis with Miglustat may reverse disease progression , 2017, Metabolic Brain Disease.

[135]  C. Whitley,et al.  Infantile gangliosidoses: Mapping a timeline of clinical changes. , 2017, Molecular genetics and metabolism.

[136]  P. Mouthuy,et al.  European contribution to the study of ROS: A summary of the findings and prospects for the future from the COST action BM1203 (EU-ROS) , 2017, Redox biology.

[137]  A. Konopka,et al.  Protein Quality Control and the Amyotrophic Lateral Sclerosis/Frontotemporal Dementia Continuum , 2017, Front. Mol. Neurosci..

[138]  S. Kölker,et al.  Linking mitochondrial dysfunction to neurodegeneration in lysosomal storage diseases , 2017, Journal of Inherited Metabolic Disease.

[139]  L. Joseph,et al.  Protective role of apigenin on rotenone induced rat model of Parkinson's disease: Suppression of neuroinflammation and oxidative stress mediated apoptosis. , 2017, Chemico-biological interactions.

[140]  A. Ciechanover,et al.  Protein Quality Control by Molecular Chaperones in Neurodegeneration , 2017, Front. Neurosci..

[141]  K. Braun Preventing cognitive impairment in children with epilepsy , 2017, Current opinion in neurology.

[142]  J. Frydman,et al.  Protein misfolding in neurodegenerative diseases: implications and strategies , 2017, Translational Neurodegeneration.

[143]  S. P. Andrews,et al.  Autophagy and Neurodegeneration: Pathogenic Mechanisms and Therapeutic Opportunities , 2017, Neuron.

[144]  V. Bohr,et al.  Cockayne syndrome: Clinical features, model systems and pathways , 2017, Ageing Research Reviews.

[145]  J. Lasselin,et al.  Role of Inflammation in Human Fatigue: Relevance of Multidimensional Assessments and Potential Neuronal Mechanisms , 2017, Front. Immunol..

[146]  Jayme L. Dahlin,et al.  The Essential Medicinal Chemistry of Curcumin , 2017, Journal of medicinal chemistry.

[147]  Dennis W Dickson,et al.  Pathology of Neurodegenerative Diseases. , 2017, Cold Spring Harbor perspectives in biology.

[148]  Andrew J. Mocle,et al.  Huntingtin is a scaffolding protein in the ATM oxidative DNA damage response complex , 2016, Human molecular genetics.

[149]  A. Bilia,et al.  Improving on Nature: The Role of Nanomedicine in the Development of Clinical Natural Drugs , 2012, Planta Medica.

[150]  A. Al-Chalabi,et al.  Amyotrophic lateral sclerosis , 2017, Nature Reviews Disease Primers.

[151]  Huaxi Xu,et al.  Dysregulation of Ubiquitin-Proteasome System in Neurodegenerative Diseases , 2016, Front. Aging Neurosci..

[152]  J. Julien,et al.  Withania somnifera Reverses Transactive Response DNA Binding Protein 43 Proteinopathy in a Mouse Model of Amyotrophic Lateral Sclerosis/Frontotemporal Lobar Degeneration , 2016, Neurotherapeutics.

[153]  Marie-Thérèse Heemels,et al.  Neurodegenerative diseases , 2016, Nature.

[154]  I. Gazaryan,et al.  The status of Nrf2-based therapeutics: current perspectives and future prospects , 2016, Neural regeneration research.

[155]  Cheng-Fu Chang,et al.  Therapeutic effect of berberine on TDP-43-related pathogenesis in FTLD and ALS , 2016, Journal of Biomedical Science.

[156]  J. Atkin,et al.  Protein folding alterations in amyotrophic lateral sclerosis , 2016, Brain Research.

[157]  Wei Zhang,et al.  Morin reverses neuropathological and cognitive impairments in APPswe/PS1dE9 mice by targeting multiple pathogenic mechanisms , 2016, Neuropharmacology.

[158]  R. Weiskirchen,et al.  Resveratrol: How Much Wine Do You Have to Drink to Stay Healthy? , 2016, Advances in nutrition.

[159]  D. Mafra,et al.  Brazil nut consumption modulates Nrf2 expression in hemodialysis patients: A pilot study. , 2016, Molecular nutrition & food research.

[160]  I. Benjamin,et al.  Heat Shock Factor 1 Is a Substrate for p38 Mitogen-Activated Protein Kinases , 2016, Molecular and Cellular Biology.

[161]  T. Kielian,et al.  Astrocytes and lysosomal storage diseases , 2016, Neuroscience.

[162]  Pamela Newland,et al.  Central fatigue in multiple sclerosis: a review of the literature , 2016, The journal of spinal cord medicine.

[163]  D. Grančai,et al.  Immunomodulatory Activity of Leaf Infusions of Selected Cornaceae Species on Human Leukocytes , 2016, Natural product communications.

[164]  G. Holmes Effect of Seizures on the Developing Brain and Cognition. , 2016, Seminars in pediatric neurology.

[165]  C. Wolfson,et al.  Fatigue and Comorbidities in Multiple Sclerosis. , 2016, International journal of MS care.

[166]  Hugo Lövheim,et al.  Microbes and Alzheimer's Disease. , 2016, Journal of Alzheimer's disease : JAD.

[167]  Xueyang Deng,et al.  Quercetin attenuates tau hyperphosphorylation and improves cognitive disorder via suppression of ER stress in a manner dependent on AMPK pathway , 2016 .

[168]  J. Quinn,et al.  Centella asiatica modulates antioxidant and mitochondrial pathways and improves cognitive function in mice. , 2016, Journal of ethnopharmacology.

[169]  D. Hirata,et al.  Natural thioallyl compounds increase oxidative stress resistance and lifespan in Caenorhabditis elegans by modulating SKN-1/Nrf , 2016, Scientific Reports.

[170]  M. Roopesh,et al.  Effect of embelin against 3-nitropropionic acid-induced Huntington's disease in rats. , 2016, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[171]  G. S. Taiwé,et al.  Antioxidant and Antifatigue Properties of the Aqueous Extract of Moringa oleifera in Rats Subjected to Forced Swimming Endurance Test , 2016, Oxidative medicine and cellular longevity.

[172]  J. Coombes,et al.  Sulforaphane and Other Nutrigenomic Nrf2 Activators: Can the Clinician's Expectation Be Matched by the Reality? , 2016, Oxidative medicine and cellular longevity.

[173]  N. Yüksel,et al.  Riluzole- and Resveratrol-Induced Delay of Retinal Ganglion Cell Death in an Experimental Model of Glaucoma , 2016, Current eye research.

[174]  M. Gharagozloo,et al.  Modulation of Cytokine Production and Transcription Factors Activities in Human Jurkat T Cells by Thymol and Carvacrol. , 2015, Advanced pharmaceutical bulletin.

[175]  Luis Carrasco,et al.  Different Brain Regions are Infected with Fungi in Alzheimer’s Disease , 2015, Scientific Reports.

[176]  G. Kim,et al.  The Role of Oxidative Stress in Neurodegenerative Diseases , 2015, Experimental neurobiology.

[177]  J. Cooper,et al.  Towards a new understanding of NCL pathogenesis. , 2015, Biochimica et biophysica acta.

[178]  Daniela Schuster,et al.  Discovery and resupply of pharmacologically active plant-derived natural products: A review , 2015, Biotechnology advances.

[179]  Shihua Li,et al.  Therapeutic Effect of Berberine on Huntington’s Disease Transgenic Mouse Model , 2015, PloS one.

[180]  F. Paul,et al.  Altered basal ganglia functional connectivity in multiple sclerosis patients with fatigue , 2015, Multiple sclerosis.

[181]  G. Macfarlane,et al.  Patients receiving anti-TNF therapies experience clinically important improvements in RA-related fatigue: results from the British Society for Rheumatology Biologics Register for Rheumatoid Arthritis. , 2015, Rheumatology.

[182]  C. Glass,et al.  The choreography of neuroinflammation in Huntington's disease. , 2015, Trends in immunology.

[183]  P. Lockhart,et al.  An open-label trial in Friedreich ataxia suggests clinical benefit with high-dose resveratrol, without effect on frataxin levels , 2015, Journal of Neurology.

[184]  Luis Carrasco,et al.  Evidence for Fungal Infection in Cerebrospinal Fluid and Brain Tissue from Patients with Amyotrophic Lateral Sclerosis , 2015, International journal of biological sciences.

[185]  J. Winkler,et al.  Adult neurogenesis in neurodegenerative diseases. , 2015, Cold Spring Harbor perspectives in biology.

[186]  O. Garaschuk,et al.  Neuroinflammation in Alzheimer's disease , 2015, The Lancet Neurology.

[187]  Jun Wang,et al.  Berberine alleviates ox-LDL induced inflammatory factors by up-regulation of autophagy via AMPK/mTOR signaling pathway , 2015, Journal of Translational Medicine.

[188]  D. Blagojević,et al.  Methanolic extract of Origanum vulgare ameliorates type 1 diabetes through antioxidant, anti-inflammatory and anti-apoptotic activity. , 2015, The British journal of nutrition.

[189]  R. Fischer,et al.  Interrelation of Oxidative Stress and Inflammation in Neurodegenerative Disease: Role of TNF , 2015, Oxidative medicine and cellular longevity.

[190]  F. Paul,et al.  Metabolic response to epigallocatechin-3-gallate in relapsing-remitting multiple sclerosis: a randomized clinical trial. , 2015, The American journal of clinical nutrition.

[191]  Yong Tae Kwon,et al.  Degradation of misfolded proteins in neurodegenerative diseases: therapeutic targets and strategies , 2015, Experimental & Molecular Medicine.

[192]  F. R. Papa,et al.  The role of endoplasmic reticulum stress in human pathology. , 2015, Annual review of pathology.

[193]  M. Berk,et al.  The Neuro-Immune Pathophysiology of Central and Peripheral Fatigue in Systemic Immune-Inflammatory and Neuro-Immune Diseases , 2015, Molecular Neurobiology.

[194]  Pengyu Ren,et al.  Allicin protects spinal cord neurons from glutamate-induced oxidative stress through regulating the heat shock protein 70/inducible nitric oxide synthase pathway. , 2015, Food & function.

[195]  Jonas Frisén,et al.  Adult Neurogenesis in Humans- Common and Unique Traits in Mammals , 2015, PLoS biology.

[196]  A. Elsayed,et al.  Nigella sativa as an anti-inflammatory and promising remyelinating agent in the cortex and hippocampus of experimental autoimmune encephalomyelitis-induced rats , 2014 .

[197]  S. Richer,et al.  Resveratrol Based Oral Nutritional Supplement Produces Long-Term Beneficial Effects on Structure and Visual Function in Human Patients , 2014, Nutrients.

[198]  J. Jankovic,et al.  Chorea associated with Huntington's disease: To treat or not to treat? , 2014, Movement disorders : official journal of the Movement Disorder Society.

[199]  F. Zipp,et al.  IL-17 and related cytokines involved in the pathology and immunotherapy of multiple sclerosis: Current and future developments. , 2014, Cytokine & growth factor reviews.

[200]  Jin Han,et al.  Echinochrome A Increases Mitochondrial Mass and Function by Modulating Mitochondrial Biogenesis Regulatory Genes , 2014, Marine drugs.

[201]  A. L. La Spada,et al.  The many faces of autophagy dysfunction in Huntington's disease: from mechanism to therapy. , 2014, Drug discovery today.

[202]  Vincenzo Bonifati,et al.  Effect of resveratrol on mitochondrial function: implications in parkin-associated familiar Parkinson's disease. , 2014, Biochimica et biophysica acta.

[203]  L. Tsai,et al.  DNA Damage and Its Links to Neurodegeneration , 2014, Neuron.

[204]  Yong-hui Shi,et al.  Effects of resveratrol on gut microbiota and fat storage in a mouse model with high-fat-induced obesity. , 2014, Food & function.

[205]  G. Paolisso,et al.  Telomerase activation: A potential key modulator for human healthspan and longevity , 2014, Ageing Research Reviews.

[206]  F. A. Resende,et al.  An Isoflavone from Dipteryx alata Vogel is Active against the in Vitro Neuromuscular Paralysis of Bothrops jararacussu Snake Venom and Bothropstoxin I, and Prevents Venom-Induced Myonecrosis , 2014, Molecules.

[207]  Mal-Soon Shin,et al.  Berberine prevents nigrostriatal dopaminergic neuronal loss and suppresses hippocampal apoptosis in mice with Parkinson's disease. , 2014, International journal of molecular medicine.

[208]  B. Oken,et al.  Physiological and functional consequences of caregiving for relatives with dementia , 2014, International Psychogeriatrics.

[209]  O. Malm,et al.  Brazil Nut (Bertholletia excelsa, H.B.K.) Improves Oxidative Stress and Inflammation Biomarkers in Hemodialysis Patients , 2014, Biological Trace Element Research.

[210]  X. Navarro,et al.  Resveratrol Improves Motoneuron Function and Extends Survival in SOD1G93A ALS Mice , 2014, Neurotherapeutics.

[211]  Thomas Sommer,et al.  Protein quality control and elimination of protein waste: the role of the ubiquitin-proteasome system. , 2014, Biochimica et biophysica acta.

[212]  H. Cai,et al.  Anti-oxidant polydatin (piceid) protects against substantia nigral motor degeneration in multiple rodent models of Parkinson’s disease , 2015, Molecular Neurodegeneration.

[213]  Sönke Arlt,et al.  Non-Alzheimer's disease—related memory impairment and dementia , 2013, Dialogues in clinical neuroscience.

[214]  R. Jaenisch,et al.  Impaired autophagy in the lipid-storage disorder Niemann-Pick type C1 disease. , 2013, Cell reports.

[215]  M. Filipič,et al.  Antigenotoxic effect of Tartary (Fagopyrum tataricum) and common (Fagopyrum esculentum) buckwheat flour. , 2013, Journal of medicinal food.

[216]  A. Aderibigbe,et al.  Studies on neuropharmacological profile of ethanol extract of Moringa oleifera leaves in mice. , 2013, Journal of ethnopharmacology.

[217]  S. Sekaran,et al.  Oil palm phenolics confer neuroprotective effects involving cognitive and motor functions in mice , 2013, Nutritional neuroscience.

[218]  J. Keller,et al.  Oxidative stress, neurodegeneration, and the balance of protein degradation and protein synthesis. , 2013, Free radical biology & medicine.

[219]  M. Unnikrishnan,et al.  Protective effect of Calendula officinalis Linn. flowers against 3-nitropropionic acid induced experimental Huntington’s disease in rats , 2013, Drug and chemical toxicology.

[220]  J. Sloan,et al.  Wisconsin Ginseng (Panax quinquefolius) to improve cancer-related fatigue: a randomized, double-blind trial, N07C2. , 2013, Journal of the National Cancer Institute.

[221]  H. Mukhtar,et al.  Fisetin: a dietary antioxidant for health promotion. , 2013, Antioxidants & redox signaling.

[222]  M. Chesselet,et al.  Mitochondrial dysfunction and oxidative stress in Parkinson's disease , 2013, Progress in Neurobiology.

[223]  Manuel Serrano,et al.  The Hallmarks of Aging , 2013, Cell.

[224]  James M. Flegal,et al.  Influence on longevity of blueberry, cinnamon, green and black tea, pomegranate, sesame, curcumin, morin, pycnogenol, quercetin, and taxifolin fed iso-calorically to long-lived, F1 hybrid mice. , 2013, Rejuvenation research.

[225]  Wim Robberecht,et al.  The changing scene of amyotrophic lateral sclerosis , 2013, Nature Reviews Neuroscience.

[226]  B. Halliwell The antioxidant paradox: less paradoxical now? , 2013, British journal of clinical pharmacology.

[227]  R. Naviaux,et al.  Alpers-Huttenlocher syndrome. , 2013, Pediatric neurology.

[228]  Y. Chien,et al.  Dysphagia as a risk factor for mortality in Niemann-Pick disease type C: systematic literature review and evidence from studies with miglustat , 2012, Orphanet Journal of Rare Diseases.

[229]  C. Saslis-Lagoudakis,et al.  Phylogenies reveal predictive power of traditional medicine in bioprospecting , 2012, Proceedings of the National Academy of Sciences.

[230]  Stefano Necozione,et al.  Benefits in Cognitive Function, Blood Pressure, and Insulin Resistance Through Cocoa Flavanol Consumption in Elderly Subjects With Mild Cognitive Impairment: The Cocoa, Cognition, and Aging (CoCoA) Study , 2012, Hypertension.

[231]  J. Kim,et al.  Ginkgo biloba extract and bilberry anthocyanins improve visual function in patients with normal tension glaucoma. , 2012, Journal of medicinal food.

[232]  A. Palamara,et al.  Infectious Agents and Neurodegeneration , 2012, Molecular Neurobiology.

[233]  Dong Hyun Kim,et al.  6-Shogaol, a ginger product, modulates neuroinflammation: A new approach to neuroprotection , 2012, Neuropharmacology.

[234]  W. Setzer,et al.  Inhibition of Essential Bacterial Peptidyl-tRNA Hydrolase Activity by Tropical Plant Extracts , 2012, Natural product communications.

[235]  M. Schulze,et al.  Critical review: vegetables and fruit in the prevention of chronic diseases , 2012, European Journal of Nutrition.

[236]  C. Cheroni,et al.  Dysfunction of constitutive and inducible ubiquitin-proteasome system in amyotrophic lateral sclerosis: Implication for protein aggregation and immune response , 2012, Progress in Neurobiology.

[237]  David J Newman,et al.  Natural products as sources of new drugs over the 30 years from 1981 to 2010. , 2012, Journal of natural products.

[238]  P. Bergmann,et al.  Inflammation-related muscle weakness and fatigue in geriatric patients , 2012, Experimental Gerontology.

[239]  Han-Ming Shen,et al.  Isorhynchophylline, a natural alkaloid, promotes the degradation of alpha-synuclein in neuronal cells via inducing autophagy , 2012, Autophagy.

[240]  E. Perry,et al.  Medicinal Plants and Dementia Therapy: Herbal Hopes for Brain Aging? , 2011, CNS neuroscience & therapeutics.

[241]  Khaled Radad,et al.  Ginsenosides and Their CNS Targets , 2011, CNS neuroscience & therapeutics.

[242]  B. Zlokovic Neurovascular pathways to neurodegeneration in Alzheimer's disease and other disorders , 2011, Nature Reviews Neuroscience.

[243]  G. Perkins,et al.  (–)‐Epicatechin enhances fatigue resistance and oxidative capacity in mouse muscle , 2011, The Journal of physiology.

[244]  A. Sartori,et al.  Uncaria tomentosa Aqueous‐ethanol Extract Triggers an Immunomodulation toward a Th2 Cytokine Profile , 2011, Phytotherapy research : PTR.

[245]  W. Robberecht,et al.  HDAC6 inhibitors reverse axonal loss in a mouse model of mutant HSPB1–induced Charcot-Marie-Tooth disease , 2011, Nature Medicine.

[246]  Andreas Bracher,et al.  Molecular chaperones in protein folding and proteostasis , 2011, Nature.

[247]  V. Bohr,et al.  DNA repair deficiency in neurodegeneration , 2011, Progress in Neurobiology.

[248]  S. Chintala,et al.  Curcumin attenuates staurosporine-mediated death of retinal ganglion cells. , 2011, Investigative ophthalmology & visual science.

[249]  D. Yoo,et al.  Grape seed extract enhances neurogenesis in the hippocampal dentate gyrus in C57BL/6 mice , 2011, Phytotherapy research : PTR.

[250]  A. Giese,et al.  Inhibition and disaggregation of α‐synuclein oligomers by natural polyphenolic compounds , 2011, FEBS letters.

[251]  Ying Sun,et al.  Isofagomine In Vivo Effects in a Neuronopathic Gaucher Disease Mouse , 2011, PloS one.

[252]  Z. Quezado,et al.  Disruption of adaptive energy metabolism and elevated ribosomal p-S6K1 levels contribute to INCL pathogenesis: partial rescue by resveratrol. , 2011, Human molecular genetics.

[253]  P. Rasoanaivo,et al.  Whole plant extracts versus single compounds for the treatment of malaria: synergy and positive interactions , 2011, Malaria Journal.

[254]  Jian-Dong Huang,et al.  Baicalein Inhibits Formation of α‐Synuclein Oligomers within Living Cells and Prevents Aβ Peptide Fibrillation and Oligomerisation , 2011, Chembiochem : a European journal of chemical biology.

[255]  K. Tufekci,et al.  The Endotoxin-Induced Neuroinflammation Model of Parkinson's Disease , 2011, Parkinson's disease.

[256]  J. Purcell,et al.  ERK activation by the polyphenols fisetin and resveratrol provides neuroprotection in multiple models of Huntington's disease. , 2011, Human molecular genetics.

[257]  T. Efferth,et al.  Complex interactions between phytochemicals. The multi-target therapeutic concept of phytotherapy. , 2011, Current drug targets.

[258]  P. Elliott,et al.  Oral Resveratrol Reduces Neuronal Damage in a Model of Multiple Sclerosis , 2010, Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society.

[259]  M. Holden,et al.  Blood cell gene expression associated with cellular stress defense is modulated by antioxidant-rich food in a randomised controlled clinical trial of male smokers , 2010, BMC medicine.

[260]  C. Garrido,et al.  Sulforaphane Activates Heat Shock Response and Enhances Proteasome Activity through Up-regulation of Hsp27* , 2010, The Journal of Biological Chemistry.

[261]  D. Green,et al.  Mitochondria and cell death: outer membrane permeabilization and beyond , 2010, Nature Reviews Molecular Cell Biology.

[262]  J. Dordick,et al.  Resveratrol Selectively Remodels Soluble Oligomers and Fibrils of Amyloid Aβ into Off-pathway Conformers* , 2010, The Journal of Biological Chemistry.

[263]  D. Lockhart,et al.  The pharmacological chaperone isofagomine increases the activity of the Gaucher disease L444P mutant form of β‐glucosidase , 2010, The FEBS journal.

[264]  D. Sulzer,et al.  CARGO RECOGNITION FAILURE IS RESPONSIBLE FOR INEFFICIENT AUTOPHAGY IN HUNTINGTON’S DISEASE , 2010, Nature Neuroscience.

[265]  S. N. Witt Hsp70 molecular chaperones and Parkinson's disease. , 2010, Biopolymers.

[266]  A. Heiseke,et al.  Autophagy, prion infection and their mutual interactions. , 2010, Current issues in molecular biology.

[267]  Martin L. Duennwald,et al.  A synergistic small molecule combination directly eradicates diverse prion strain structures , 2009, Nature chemical biology.

[268]  G. Parenti Treating lysosomal storage diseases with pharmacological chaperones: from concept to clinics , 2009, EMBO molecular medicine.

[269]  Kirandeep Kaur,et al.  Antimalarials from nature. , 2009, Bioorganic & medicinal chemistry.

[270]  J. Nam,et al.  Anti‐inflammatory activity of p‐coumaryl alcohol‐γ‐O‐methyl ether is mediated through modulation of interferon‐γ production in Th cells , 2009, British journal of pharmacology.

[271]  E. Hwang,et al.  Effect of naturally occurring hydroxychavicol acetate on the cytokine production in T helper cells. , 2009, International immunopharmacology.

[272]  B. Falsini,et al.  Effect of epigallocatechin-gallate on inner retinal function in ocular hypertension and glaucoma: A short-term study by pattern electroretinogram , 2009, Graefe's Archive for Clinical and Experimental Ophthalmology.

[273]  M. McGrath,et al.  Circulating endotoxin and systemic immune activation in sporadic amyotrophic lateral sclerosis (sALS) , 2009, Journal of Neuroimmunology.

[274]  E. Hirsch,et al.  Infiltration of CD4+ lymphocytes into the brain contributes to neurodegeneration in a mouse model of Parkinson disease. , 2008, The Journal of clinical investigation.

[275]  Nilüfer Orhan,et al.  Biological activities of Vitis vinifera L. leaves , 2009 .

[276]  P. Houghton Synergy and polyvalence : paradigms to explain the activity of herbal products , 2009 .

[277]  D. Dhanasekaran,et al.  JNK signaling in apoptosis , 2008, Oncogene.

[278]  L. Leocani,et al.  Physiopathology of fatigue in Multiple Sclerosis , 2008, Neurological Sciences.

[279]  Nicola Brunetti-Pierri,et al.  GM1 gangliosidosis: review of clinical, molecular, and therapeutic aspects. , 2008, Molecular genetics and metabolism.

[280]  Y. Hwang,et al.  The coffee diterpene kahweol induces heme oxygenase‐1 via the PI3K and p38/Nrf2 pathway to protect human dopaminergic neurons from 6‐hydroxydopamine‐derived oxidative stress , 2008, FEBS letters.

[281]  Guido Kroemer,et al.  Autophagy in the Pathogenesis of Disease , 2008, Cell.

[282]  Howard Schulman,et al.  Global changes to the ubiquitin system in Huntington's disease , 2007, Nature.

[283]  S. Elmore Apoptosis: A Review of Programmed Cell Death , 2007, Toxicologic pathology.

[284]  K. Doh-ura,et al.  Prophylactic Effect of Dietary Seaweed Fucoidan against Enteral Prion Infection , 2007, Antimicrobial Agents and Chemotherapy.

[285]  F. Walker Huntington's disease , 2007, The Lancet.

[286]  M. Fang,et al.  Dietary polyphenols may affect DNA methylation. , 2007, The Journal of nutrition.

[287]  C. Lorson,et al.  Induction of full-length survival motor neuron by polyphenol botanical compounds , 2007, Human Genetics.

[288]  Susan Lindquist,et al.  Green tea (-)-epigallocatechin-gallate modulates early events in huntingtin misfolding and reduces toxicity in Huntington's disease models. , 2006, Human molecular genetics.

[289]  K. G. Mohandas Rao,et al.  Centella asiatica (L.) Leaf Extract Treatment During the Growth Spurt Period Enhances Hippocampal CA3 Neuronal Dendritic Arborization in Rats , 2006, Evidence-based complementary and alternative medicine : eCAM.

[290]  Kenjiro Ono,et al.  Antioxidant compounds have potent anti‐fibrillogenic and fibril‐destabilizing effects for α‐synuclein fibrils in vitro , 2006, Journal of neurochemistry.

[291]  Marcy J. Balunas,et al.  Drug discovery from medicinal plants. , 2005, Life sciences.

[292]  Wieland Peschel,et al.  Understanding local Mediterranean diets: a multidisciplinary pharmacological and ethnobotanical approach. , 2005, Pharmacological research.

[293]  Christine D. Dijkstra,et al.  Flavonoids Influence Monocytic GTPase Activity and Are Protective in Experimental Allergic Encephalitis , 2004, The Journal of experimental medicine.

[294]  B. Caughey,et al.  Evaluation of new cell culture inhibitors of protease-resistant prion protein against scrapie infection in mice. , 2004, The Journal of general virology.

[295]  A. Chaudhuri,et al.  Fatigue in neurological disorders , 2004, The Lancet.

[296]  P. Mecocci,et al.  Plasma antioxidants are similarly depleted in mild cognitive impairment and in Alzheimer’s disease , 2003, Neurobiology of Aging.

[297]  B. Caughey,et al.  New Inhibitors of Scrapie-Associated Prion Protein Formation in a Library of 2,000 Drugs and Natural Products , 2003, Journal of Virology.

[298]  L. Hoey,et al.  Bioavailability of phyto-oestrogens , 2003, British Journal of Nutrition.

[299]  Mohammad Reza Mohammadi,et al.  Salvia officinalis extract in the treatment of patients with mild to moderate Alzheimer's disease: a double blind, randomized and placebo‐controlled trial , 2003, Journal of clinical pharmacy and therapeutics.

[300]  G. Kroemer,et al.  Heat shock proteins: endogenous modulators of apoptotic cell death. , 2001, Biochemical and biophysical research communications.

[301]  C. Pickart,et al.  Mechanisms underlying ubiquitination. , 2001, Annual review of biochemistry.

[302]  Y. Sheng,et al.  DNA repair enhancement of aqueous extracts of Uncaria tomentosa in a human volunteer study. , 2001, Phytomedicine : international journal of phytotherapy and phytopharmacology.

[303]  J. Turnbull,et al.  Beneficial effect of ginseng root in SOD-1 (G93A) transgenic mice , 2000, Journal of the Neurological Sciences.

[304]  I. Khafagi,et al.  The efficiency of random versus ethno-directed research in the evaluation of Sinai medicinal plants for bioactive compounds. , 2000, Journal of ethnopharmacology.

[305]  B. Halliwell The antioxidant paradox , 2000, The Lancet.

[306]  V. Singh,et al.  The paradigm of Th1 and Th2 cytokines , 1999, Immunologic research.

[307]  Barbara Shukitt-Hale,et al.  Reversals of Age-Related Declines in Neuronal Signal Transduction, Cognitive, and Motor Behavioral Deficits with Blueberry, Spinach, or Strawberry Dietary Supplementation , 1999, The Journal of Neuroscience.

[308]  G M Cohen,et al.  Caspases: the executioners of apoptosis. , 1997, The Biochemical journal.

[309]  G. Wilcock,et al.  Herpes simplex virus type 1 in brain and risk of Alzheimer's disease , 1997, The Lancet.

[310]  K. H. Park,et al.  Transcriptional activation of the Cu,Zn-superoxide dismutase gene through the AP2 site by ginsenoside Rb2 extracted from a medicinal plant, Panax ginseng. , 1996, The Journal of biological chemistry.

[311]  A. Krettli,et al.  Survey of medicinal plants used as antimalarials in the Amazon. , 1992, Journal of ethnopharmacology.

[312]  K. Ono,et al.  Differential inhibitory effects of various herb extracts on the activities of reverse transcriptase and various deoxyribonucleic acid (DNA) polymerases. , 1989, Chemical & pharmaceutical bulletin.

[313]  C. Malmsten,et al.  Prostaglandins, thromboxanes, and leukotrienes in inflammation. , 1986, The American journal of medicine.

[314]  R. Ferrante,et al.  Neuropathological Classification of Huntington's Disease , 1985, Journal of neuropathology and experimental neurology.

[315]  C. Sigurdson,et al.  [Prion diseases?]. , 1985, Deutsche medizinische Wochenschrift.

[316]  A. Wyllie,et al.  Apoptosis: A Basic Biological Phenomenon with Wide-ranging Implications in Tissue Kinetics , 1972, British Journal of Cancer.